NASDAQ$BTTC

Black Titan Corp · Q3 2012 earnings

Q3 2012 earnings · Reported Nov 9, 2012 (14 years ago) · Investor relations

Nov 9Sep 30, 2012

Total Revenue

$1.23M

Previous: $1.01M+21.3%

EPS (adj)

-$3.60

Previous: -$13.40+73.1%

Capital Expenditures

$133K

No prior period

Free Cash Flow

-$2.51M

No prior period

Net Income

-$8.01M

Previous: -$804K-896.6%

Operating Income

-$2.66M

Previous: -$1.96M-35.8%

Gross Profit

-$1.77M

Previous: $1.01M-274.6%

Cash & Equivalents

$5.06M

No prior period

Total Assets

$10.7M

No prior period

Stock-Based Comp

$365K

No prior period

Titan Pharmaceuticals · Revenue · Quarterly

$1.23M

Q3 2012+21.3%vs Q3 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation